| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |